U.S. Cell Separation Market Size & Outlook, 2025-2033
Related Markets
U.S. cell separation market highlights
- The U.S. cell separation market generated a revenue of USD 3,102.5 million in 2024 and is expected to reach USD 7,478.0 million by 2033.
- The U.S. market is expected to grow at a CAGR of 10.6% from 2025 to 2033.
- In terms of segment, consumables was the largest revenue generating product in 2024.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cell separation market data book summary
| Market revenue in 2024 | USD 3,102.5 million |
| Market revenue in 2033 | USD 7,478.0 million |
| Growth rate | 10.6% (CAGR from 2025 to 2033) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments |
| Key market players worldwide | Thermo Fisher Scientific Inc, BD, Danaher Corp, Terumo Corp, STEMCELL Technologies, Bio-Rad Laboratories Inc, Merck KGaA, Agilent Technologies Inc, Corning Inc, Akadeum Life Sciences |
Other key industry trends
- In terms of revenue, U.S. accounted for 32.2% of the global cell separation market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. cell separation market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 7,478.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Separation Market Scope
Cell Separation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Akadeum Life Sciences | View profile | 11-50 | Ann Arbor, Michigan, United States, North America | http://akadeum.com |
| STEMCELL Technologies | View profile | 501-1000 | Vancouver, British Columbia, Canada, North America | https://www.stemcell.com |
| Corning Inc | View profile | 49800 | One Riverfront Plaza, Corning, NY, United States, 14831 | https://www.corning.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
U.S. cell separation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell separation market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 65.41% in 2024. Horizon Databook has segmented the U.S. cell separation market based on consumables, instruments covering the revenue growth of each sub-segment from 2021 to 2033.
The U.S. market for cell separation is expected to witness lucrative growth as it is the biggest market for biotechnology & biopharmaceuticals and a leader in biopharmaceutical R&D. According to data published by PhRMA in 2018, the U.S. biopharmaceutical industry invested around USD 102 billion in R&D activities.
Furthermore, high prevalence of chronic diseases, such as cancer, and extensive R&D activities by regional players to develop novel cell & gene therapies are expected to fuel the demand for cell separation solutions. As per American Cancer Society’s estimates, in 2021, around 1.9 million new cases of cancer were estimated to be diagnosed in the U.S., with over 608,570 cancer-related deaths.
In addition, following the outbreak of COVID‐19, several U.S.-based companies involved in extensive research for development of novel vaccines and therapeutics, driving the demand for cell separation solutions for various research applications. Furthermore, local presence of major players like Thermo Fisher Scientific, BD, & Danaher in the country and strategic initiatives undertaken by them are anticipated to fuel the market growth.
Reasons to subscribe to U.S. cell separation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. cell separation market databook
-
Our clientele includes a mix of cell separation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. cell separation market , including forecasts for subscribers. This country databook contains high-level insights into U.S. cell separation market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
US Consumables - Cell Separation Market, 2024 - 2033 (US$M)
U.S. Cell Separation Market Outlook Share, 2024 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
